Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Reis Marques

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Antipsychotics, versatility in actionSidharth Mahapatra, Tiago Reis Marques
JAMA Psychiatry|January 10, 2016
Dopamine, Striatum, Antipsychotics, and Questions About Weight GainShitij Kapur, Tiago Reis Marques
JAMA Psychiatry|October 31, 2019
Treatment of First-Episode Schizophrenia in a Young WomanRobert A McCutcheon, Tiago Reis Marques, Oliver D Howes
JAMA Psychiatry|October 31, 2019
Schizophrenia-An OverviewRobert A McCutcheon, Tiago Reis Marques, Oliver D Howes
Bjpsych Open|October 27, 2021
Mental health risk factors during the first wave of the COVID-19 pandemicHenrique Prata Ribeiro, André Ponte, Miguel Raimundo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2019
Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studiesStephen J Kaar, Ilinca Angelescu, Tiago Reis Marques, et al.
Molecular Psychiatry|March 8, 2018
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measuresEmanuele Felice Osimo, Katherine Beck, Tiago Reis Marques, et al.
Drug Safety|June 3, 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position PaperFernando Barata, Carlos Aguiar, Tiago Reis Marques, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2020
Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS studyFaith Borgan, Mattia Veronese, Tiago Reis Marques, et al.
Clinical EEG and Neuroscience|January 2, 2023
Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic DysfunctionStephen J Kaar, Judith F Nottage, Ilinca Angelescu, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2021
Antipsychotics, versatility in actionSidharth Mahapatra, Tiago Reis Marques
JAMA Psychiatry|January 10, 2016
Dopamine, Striatum, Antipsychotics, and Questions About Weight GainShitij Kapur, Tiago Reis Marques
JAMA Psychiatry|October 31, 2019
Treatment of First-Episode Schizophrenia in a Young WomanRobert A McCutcheon, Tiago Reis Marques, Oliver D Howes
JAMA Psychiatry|October 31, 2019
Schizophrenia-An OverviewRobert A McCutcheon, Tiago Reis Marques, Oliver D Howes
Bjpsych Open|October 27, 2021
Mental health risk factors during the first wave of the COVID-19 pandemicHenrique Prata Ribeiro, André Ponte, Miguel Raimundo, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 19, 2019
Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studiesStephen J Kaar, Ilinca Angelescu, Tiago Reis Marques, et al.
Molecular Psychiatry|March 8, 2018
Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measuresEmanuele Felice Osimo, Katherine Beck, Tiago Reis Marques, et al.
Drug Safety|June 3, 2021
Monitoring and Managing Lorlatinib Adverse Events in the Portuguese Clinical Setting: A Position PaperFernando Barata, Carlos Aguiar, Tiago Reis Marques, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2020
Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS studyFaith Borgan, Mattia Veronese, Tiago Reis Marques, et al.
Clinical EEG and Neuroscience|January 2, 2023
Gamma Oscillations and Potassium Channel Modulation in Schizophrenia: Targeting GABAergic DysfunctionStephen J Kaar, Judith F Nottage, Ilinca Angelescu, et al.
Pageof 11